Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 670.43Cr 100.06Cr 87Cr 82Cr 75Cr 140.76Cr 9.57TCr 140.79Cr 986.38Cr 380.62Cr 4.89TCr 375.78Cr 367.54Cr 16TCr P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 421.21Cr 63Cr 55Cr 52Cr 47Cr 88Cr 6.01TCr 88Cr 619.72Cr 239.13Cr 3.07TCr 236.09Cr 230.92Cr 9.89TCr EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-0.26%
1 week+0.35%
Current month-3.45%
1 month-11.96%
3 months-5.12%
6 months-7.42%
Current year-22.27%
1 week 11.16
Extreme 11.16
11.58
1 month 11.16
Extreme 11.16
13.48
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
15.66
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 58 09/02/2026
Director of Finance/CFO 49 06/12/2021
Corporate Officer/Principal 56 20/03/2025
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
17/07/24 Buy 500 0.0001%
22/01/20 Sell

Director

2,46,300 0.0462%
01/01/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+0.35%-26.69%-51.07% 100.38Cr
+0.45%+1.10%-12.24%-3.06% 1.36TCr
0.00%+0.38%-31.99%-55.53% 484.56Cr
+0.33%-1.55%-4.35%-5.10% 434.58Cr
-0.06%+1.30%-5.35%-30.85% 388.95Cr
-0.88%-2.64%-2.83%-4.48% 343.55Cr
-0.28%+1.36%-20.30%+5.09% 350.26Cr
-0.85%-0.43%-10.75%+3.49% 313.89Cr
0.00%+1.03%-20.89%-16.22% 228.92Cr
+0.20%+3.05%-25.76%-20.97% 168.46Cr
Average -0.13%+1.22%-16.12%-17.87% 417.48Cr
Weighted average by Cap. +0.02%+1.03%-14.23%-13.49%

Financials

2024 2025
Net sales 337.7Cr 50Cr 44Cr 41Cr 38Cr 71Cr 4.82TCr 71Cr 496.85Cr 191.72Cr 2.46TCr 189.28Cr 185.14Cr 7.93TCr 231.8Cr 35Cr 30Cr 28Cr 26Cr 49Cr 3.31TCr 49Cr 341.03Cr 131.6Cr 1.69TCr 129.92Cr 127.07Cr 5.44TCr
Net income 49Cr 7.34Cr 6.42Cr 6.03Cr 5.5Cr 10Cr 702.05Cr 10Cr 72Cr 28Cr 358.52Cr 28Cr 27Cr 1.16TCr -26Cr -3.85Cr -3.36Cr -3.16Cr -2.88Cr -5.41Cr -367.87Cr -5.41Cr -38Cr -15Cr -187.86Cr -14Cr -14Cr -605.63Cr
Net Debt -228.95Cr -34Cr -30Cr -28Cr -26Cr -48Cr -3.27TCr -48Cr -336.84Cr -129.98Cr -1.67TCr -128.33Cr -125.51Cr -5.38TCr -249.22Cr -37Cr -33Cr -31Cr -28Cr -52Cr -3.56TCr -52Cr -366.66Cr -141.49Cr -1.82TCr -139.69Cr -136.62Cr -5.85TCr
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
22/26/22 CN¥11.48 -0.26% 38,38,814
21/26/21 CN¥11.51 +2.31% 59,07,230
18/26/18 CN¥11.25 +0.27% 35,47,019
17/26/17 CN¥11.22 -0.27% 24,94,499
16/26/16 CN¥11.25 -0.53% 28,74,543

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!